Systemic high-dose intravenous methotrexate for central nervous system metastases

By Lassman Andrew   Abrey Lauren   Shah Gaurav   Panageas Katherine   Begemann Martin   Malkin Mark   Raizer Jeffrey  

Journal of Neuro-Oncology, Vol. 78, Iss. 3, 2006-07 ,pp. : 255-260

Springer Publishing Company

Access to resources Recommend Favorite

Immunohistological profiling by B-cell differentiation status of primary central nervous system lymphoma treated by high-dose methotrexate chemotherapy

By Kinoshita Manabu   Hashimoto Naoya   Izumoto Shuichi   Okita Yoshiko   Kagawa Naoki   Maruno Motohiko   Ohnishi Takanori   Arita Norio   Yoshimine Toshiki  

Journal of Neuro-Oncology, Vol. 99, Iss. 1, 2010-08 ,pp. : 95-101

Springer Publishing Company

Access to resources Recommend Favorite

High-dose intravenous rituximab for multifocal, monomorphic primary central nervous system posttransplant lymphoproliferative disorder

By Patrick A.   Wee A.   Hedderman A.   Wilson D.   Weiss J.   Govani M.  

Journal of Neuro-Oncology, Vol. 103, Iss. 3, 2011-07 ,pp. : 739-743

Springer Publishing Company

Access to resources Recommend Favorite

Use of rituximab in combination with high-dose methotrexate in the treatment of primary central nervous system lymphoma in a mycophenolate mofetil treated patient with lupus nephritis

By Lai Gillianne Geet Yi   Koo Yu Xuan   Tao Miriam   Tan Thuan Tong   Lim Soon-Thye  

Acta Oncologica, Vol. 50, Iss. 1, 2011-01 ,pp. : 144-145

Informa Healthcare

Access to resources Recommend Favorite

High-dose chemotherapy with hematopoietic stem cell transplantation for the treatment of primary central nervous system lymphoma

By Campen Christopher   Tombleson Rebecca   Green Myke  

Journal of Neuro-Oncology, Vol. 101, Iss. 3, 2011-02 ,pp. : 345-355

Springer Publishing Company

Access to resources Recommend Favorite